Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-55.87%EBITDA Margin
VS
Market
Sector
Industry
History
$ 1.52Close
$ 1.51 - $ 9.22 52-Week Range
Ticker Information
Ticker
LUNGCompany Name
PULMONX CORPSector
HealthcareIndustry
Medical DevicesExchange
NASDAQPULMONX CORP - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LUNG - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -50.59M | -55.87% | $ 90.55M |
| 3/31/2025 | $ -50.39M | -57.6% | $ 87.47M |
| 12/31/2024 | $ -49.05M | -58.54% | $ 83.79M |
| 9/30/2024 | $ -49.14M | -61.97% | $ 79.3M |
| 6/30/2024 | $ -49.62M | -64.79% | $ 76.58M |
| 3/31/2024 | $ -50.29M | -68.89% | $ 72.99M |
| 12/31/2023 | $ -52.81M | -76.89% | $ 68.67M |
| 9/30/2023 | $ -53.7M | -82.84% | $ 64.82M |
| 6/30/2023 | $ -53.71M | -88.55% | $ 60.66M |
| 3/31/2023 | $ -52.99M | -92.29% | $ 57.41M |
Key Performance Insights, Last 5 Years
- PULMONX CORP's latest trailing twelve months (TTM) EBITDA % stands at -82.14%.
- Over the past 5 years, PULMONX CORP's average EBITDA % has been -79.93%.
- The median EBITDA % for PULMONX CORP during this period was -82.49%
- PULMONX CORP reached its highest EBITDA % over the past 5 years at -55.87%.
- The lowest EBITDA % recorded by PULMONX CORP in the same timeframe -101.12%
PULMONX CORP's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for PULMONX CORP is calculated as follows: EBITDA [ $ -26.89M ] / Revenues [ $ 32.73M ]
(=) EBITDA % [ -82.14% ] LUNG - EBITDA Margin, Last 5 years
-101.12%
Minimum
Sep 30, 2022
-55.87%
Maximum
Jun 30, 2025
-79.93%
Average
-82.49%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -75.07% |
| max | 97.73% |
| average | 16.12% |
| median | 14.72% |
| std | 26.88% |